IBDEI0HT ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8314,0)
 ;;=054.13^^35^483^37
 ;;^UTILITY(U,$J,358.3,8314,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8314,1,4,0)
 ;;=4^054.13
 ;;^UTILITY(U,$J,358.3,8314,1,5,0)
 ;;=5^Herpetic Infect Of Penis
 ;;^UTILITY(U,$J,358.3,8314,2)
 ;;=^266560
 ;;^UTILITY(U,$J,358.3,8315,0)
 ;;=054.11^^35^483^38
 ;;^UTILITY(U,$J,358.3,8315,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8315,1,4,0)
 ;;=4^054.11
 ;;^UTILITY(U,$J,358.3,8315,1,5,0)
 ;;=5^Herpetic Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,8315,2)
 ;;=^57012
 ;;^UTILITY(U,$J,358.3,8316,0)
 ;;=053.9^^35^483^36
 ;;^UTILITY(U,$J,358.3,8316,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8316,1,4,0)
 ;;=4^053.9
 ;;^UTILITY(U,$J,358.3,8316,1,5,0)
 ;;=5^Herpes Zoster NOS
 ;;^UTILITY(U,$J,358.3,8316,2)
 ;;=^56946
 ;;^UTILITY(U,$J,358.3,8317,0)
 ;;=487.1^^35^483^39
 ;;^UTILITY(U,$J,358.3,8317,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8317,1,4,0)
 ;;=4^487.1
 ;;^UTILITY(U,$J,358.3,8317,1,5,0)
 ;;=5^Influenza
 ;;^UTILITY(U,$J,358.3,8317,2)
 ;;=^63125
 ;;^UTILITY(U,$J,358.3,8318,0)
 ;;=487.0^^35^483^40
 ;;^UTILITY(U,$J,358.3,8318,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8318,1,4,0)
 ;;=4^487.0
 ;;^UTILITY(U,$J,358.3,8318,1,5,0)
 ;;=5^Influenza W/ Pneumonia
 ;;^UTILITY(U,$J,358.3,8318,2)
 ;;=^269942
 ;;^UTILITY(U,$J,358.3,8319,0)
 ;;=386.30^^35^483^41
 ;;^UTILITY(U,$J,358.3,8319,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8319,1,4,0)
 ;;=4^386.30
 ;;^UTILITY(U,$J,358.3,8319,1,5,0)
 ;;=5^Labyrinthitis NOS
 ;;^UTILITY(U,$J,358.3,8319,2)
 ;;=^67891
 ;;^UTILITY(U,$J,358.3,8320,0)
 ;;=088.81^^35^483^42
 ;;^UTILITY(U,$J,358.3,8320,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8320,1,4,0)
 ;;=4^088.81
 ;;^UTILITY(U,$J,358.3,8320,1,5,0)
 ;;=5^Lyme Disease
 ;;^UTILITY(U,$J,358.3,8320,2)
 ;;=^72315
 ;;^UTILITY(U,$J,358.3,8321,0)
 ;;=785.6^^35^483^43
 ;;^UTILITY(U,$J,358.3,8321,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8321,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,8321,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,8321,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,8322,0)
 ;;=031.0^^35^483^44
 ;;^UTILITY(U,$J,358.3,8322,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8322,1,4,0)
 ;;=4^031.0
 ;;^UTILITY(U,$J,358.3,8322,1,5,0)
 ;;=5^Mycobacteria,Atyp,Pulmonary
 ;;^UTILITY(U,$J,358.3,8322,2)
 ;;=^101018
 ;;^UTILITY(U,$J,358.3,8323,0)
 ;;=730.00^^35^483^46
 ;;^UTILITY(U,$J,358.3,8323,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8323,1,4,0)
 ;;=4^730.00
 ;;^UTILITY(U,$J,358.3,8323,1,5,0)
 ;;=5^Osteomyelitis,Acute Unsp
 ;;^UTILITY(U,$J,358.3,8323,2)
 ;;=^272612
 ;;^UTILITY(U,$J,358.3,8324,0)
 ;;=730.10^^35^483^47
 ;;^UTILITY(U,$J,358.3,8324,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8324,1,4,0)
 ;;=4^730.10
 ;;^UTILITY(U,$J,358.3,8324,1,5,0)
 ;;=5^Osteomyelitis,Chron Unsp
 ;;^UTILITY(U,$J,358.3,8324,2)
 ;;=^24427
 ;;^UTILITY(U,$J,358.3,8325,0)
 ;;=380.10^^35^483^48
 ;;^UTILITY(U,$J,358.3,8325,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8325,1,4,0)
 ;;=4^380.10
 ;;^UTILITY(U,$J,358.3,8325,1,5,0)
 ;;=5^Otitis Externa 
 ;;^UTILITY(U,$J,358.3,8325,2)
 ;;=380.10^62807
 ;;^UTILITY(U,$J,358.3,8326,0)
 ;;=382.9^^35^483^49
 ;;^UTILITY(U,$J,358.3,8326,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8326,1,4,0)
 ;;=4^382.9
 ;;^UTILITY(U,$J,358.3,8326,1,5,0)
 ;;=5^Otitis Media
 ;;^UTILITY(U,$J,358.3,8326,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,8327,0)
 ;;=614.9^^35^483^50
 ;;^UTILITY(U,$J,358.3,8327,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8327,1,4,0)
 ;;=4^614.9
 ;;^UTILITY(U,$J,358.3,8327,1,5,0)
 ;;=5^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,8327,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,8328,0)
 ;;=486.^^35^483^52
 ;;
 ;;$END ROU IBDEI0HT
